10X Genomics (TXG) Proxy filing summary

Executive summary

• The 2026 Annual Meeting will be held virtually on June 4, 2026, with voting on director elections, auditor ratification, and executive compensation approval.

• Shareholders can vote online, by phone, or mail, and may submit questions during the meeting.

• The board recommends voting FOR all proposals, including the election of three Class I directors for three-year terms.

Voting matters and shareholder proposals

• Proposal One: Election of three Class I directors to serve until 2029.

• Proposal Two: Ratification of Ernst & Young LLP as independent auditor for 2026.

• Proposal Three: Advisory vote to approve executive compensation (Say on Pay).

• Shareholders may submit proposals for the 2027 meeting by December 15, 2026, and nominate directors per bylaw procedures.

Board of directors and corporate governance

• Board consists of eight members with staggered three-year terms; six are independent.

• Committees: Audit, Compensation, Nominating & Corporate Governance, and Mergers & Acquisitions, all with independent members.

• Separate Chair and CEO roles; annual board and committee self-assessments.

• Stock ownership and clawback policies in place; no poison pill.